胰腺癌：流行病学变化及风险评估、早期检测和预防的新方法。
Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
机构信息
Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, Michigan.
Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
出版信息
Gastroenterology. 2023 Apr;164(5):752-765. doi: 10.1053/j.gastro.2023.02.012. Epub 2023 Feb 18.
Abstract
Pancreatic cancer usually results in poor survival with limited options for treatment, as most affected individuals present with advanced disease. Early detection of preinvasive pancreatic neoplasia and identifying molecular therapeutic targets provide opportunities for extending survival. Although screening for pancreatic cancer is currently not recommended for the general population, emerging evidence indicates that pancreatic surveillance can improve outcomes for individuals in certain high-risk groups. Changes in the epidemiology of pancreatic cancer, experience from pancreatic surveillance, and discovery of novel biomarkers provide a roadmap for new strategies for pancreatic cancer risk assessment, early detection, and prevention.
摘要
胰腺癌通常导致预后不良，治疗选择有限，因为大多数受影响的个体都处于疾病晚期。早期发现癌前胰腺肿瘤并确定分子治疗靶点为延长生存期提供了机会。虽然目前不建议对普通人群进行胰腺癌筛查，但新出现的证据表明，胰腺监测可以改善某些高危人群的预后。胰腺癌流行病学的变化、胰腺监测的经验以及新型生物标志物的发现为胰腺癌风险评估、早期检测和预防的新策略提供了路线图。
相似文献
1
Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.胰腺癌：流行病学变化及风险评估、早期检测和预防的新方法。
Gastroenterology. 2023 Apr;164(5):752-765. doi: 10.1053/j.gastro.2023.02.012. Epub 2023 Feb 18.
2
Early detection and prevention of pancreatic cancer: is it really possible today?胰腺癌的早期检测与预防：如今真的可行吗？
World J Gastroenterol. 2014 Sep 14;20(34):12118-31. doi: 10.3748/wjg.v20.i34.12118.
3
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer.胰腺癌高危个体的监测方面与结果
Fam Cancer. 2024 Aug;23(3):323-339. doi: 10.1007/s10689-024-00368-1. Epub 2024 Apr 15.
4
Screening and early detection of pancreatic cancer in high risk population.高危人群胰腺癌的筛查与早期检测
World J Gastroenterol. 2014 Mar 7;20(9):2358-64. doi: 10.3748/wjg.v20.i9.2358.
5
Screening for pancreatic cancer in familial high-risk individuals: A systematic review.对家族性高危个体进行胰腺癌筛查：一项系统评价。
World J Gastroenterol. 2015 Jul 28;21(28):8678-86. doi: 10.3748/wjg.v21.i28.8678.
6
Strategies for early detection of resectable pancreatic cancer.可切除胰腺癌的早期检测策略。
World J Gastroenterol. 2014 Aug 28;20(32):11230-40. doi: 10.3748/wjg.v20.i32.11230.
7
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.胰腺癌：临床诊断、流行病学、治疗和结局的综述。
World J Gastroenterol. 2018 Nov 21;24(43):4846-4861. doi: 10.3748/wjg.v24.i43.4846.
8
Challenges and Opportunities in Pancreatic Cancer Screening Among High-Risk Individuals.高危个体胰腺癌筛查中的挑战与机遇
Gastroenterology. 2022 Jun;162(7):2113-2120. doi: 10.1053/j.gastro.2022.03.040. Epub 2022 Mar 29.
9
Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.内镜超声在家族性胰腺癌高危人群筛查和随访中的作用。
World J Gastroenterol. 2019 Sep 14;25(34):5082-5096. doi: 10.3748/wjg.v25.i34.5082.
10
Screening for Pancreatic Cancer.胰腺癌筛查
Surg Clin North Am. 2016 Dec;96(6):1223-1233. doi: 10.1016/j.suc.2016.07.016.
引用本文的文献
1
Minimally Invasive Pancreatoduodenectomy Compared to Open Pancreatoduodenectomy in Patients With Pancreatic Cancer: A Systematic Review.胰腺癌患者中微创胰十二指肠切除术与开放胰十二指肠切除术的比较：一项系统评价
Cureus. 2025 Aug 2;17(8):e89264. doi: 10.7759/cureus.89264. eCollection 2025 Aug.
2
Evaluating cadonilimab efficacy and safety in retrospective first line treatment for advanced pancreatic cancer.评估卡度尼利单抗在晚期胰腺癌一线回顾性治疗中的疗效和安全性。
iScience. 2025 Jul 17;28(9):113136. doi: 10.1016/j.isci.2025.113136. eCollection 2025 Sep 19.
3
Correlation of pathological types and imaging features in pancreatic cancer.胰腺癌的病理类型与影像学特征的相关性
World J Gastrointest Oncol. 2025 Aug 15;17(8):102757. doi: 10.4251/wjgo.v17.i8.102757.
4
The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via miR-188-5p/CDCA3/TRAF2-mediated remodeling of NF-κB signaling pathway.脱氧地胆草素潜在靶标circTNPO3通过miR-188-5p/CDCA3/TRAF2介导的NF-κB信号通路重塑在调节胰腺癌恶性表型和吉西他滨化疗耐药中的功能作用
Front Pharmacol. 2025 Jul 31;16:1613560. doi: 10.3389/fphar.2025.1613560. eCollection 2025.
5
The efficacy of early progressive resistance exercise in the postoperative management of pancreaticoduodenectomy for pancreatic cancer: a randomized controlled trial.早期渐进性抗阻运动在胰腺癌胰十二指肠切除术后管理中的疗效：一项随机对照试验。
Front Surg. 2025 Aug 1;12:1609788. doi: 10.3389/fsurg.2025.1609788. eCollection 2025.
6
The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome.免疫相关预后基因AIM2通过炎性小体促进胰腺癌进展。
Sci Rep. 2025 Aug 13;15(1):29733. doi: 10.1038/s41598-025-12651-x.
7
Preoperative MRI and CA19-9 for predicting occult lymph node metastasis in small pancreatic ductal adenocarcinoma (≤ 2 cm).术前MRI和CA19-9用于预测小胰腺癌（≤2cm）的隐匿性淋巴结转移。
BMC Med Imaging. 2025 Aug 6;25(1):318. doi: 10.1186/s12880-025-01854-3.
8
Exploring the causal relationship between hemoglobin and pancreatic cancer and its potential mechanisms through bioinformatics and Mendelian randomization.通过生物信息学和孟德尔随机化探索血红蛋白与胰腺癌之间的因果关系及其潜在机制。
Discov Oncol. 2025 Aug 5;16(1):1472. doi: 10.1007/s12672-025-03352-y.
9
Hes1 in malignant tumors: from molecular mechanism to therapeutic potential.恶性肿瘤中的Hes1：从分子机制到治疗潜力
Front Immunol. 2025 Jul 18;16:1585624. doi: 10.3389/fimmu.2025.1585624. eCollection 2025.
10
CTHRC1 Derived From Cancer-Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF-STAT3 Pathway.源自癌症相关成纤维细胞的CTHRC1通过LIF-STAT3途径促进胰腺癌进展和转移。
Cancer Med. 2025 Aug;14(15):e71126. doi: 10.1002/cam4.71126.
本文引用的文献
1
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data.基于血液的蛋白质生物标志物对胰腺癌的诊断准确性及附加价值：汇总数据和个体参与者数据的荟萃分析
EClinicalMedicine. 2022 Nov 24;55:101747. doi: 10.1016/j.eclinm.2022.101747. eCollection 2023 Jan.
2
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.新辅助化疗后接受手术切除的胰腺癌患者病理反应的种族差异：来自胰腺中央联盟的多机构分析
Ann Surg Oncol. 2023 Mar;30(3):1485-1494. doi: 10.1245/s10434-022-12741-4. Epub 2022 Oct 31.
3
Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.前瞻性、多机构、实时下一代测序胰腺囊液揭示了多种基因组改变，改善了胰腺囊肿的临床管理。
Gastroenterology. 2023 Jan;164(1):117-133.e7. doi: 10.1053/j.gastro.2022.09.028. Epub 2022 Oct 6.
4
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis.过去三十年中胰腺癌发病率和死亡率的国际趋势：一个联合回归分析。
World J Gastroenterol. 2022 Aug 28;28(32):4698-4715. doi: 10.3748/wjg.v28.i32.4698.
5
Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study.影像学中胰腺癌的漏诊和误诊的发生率、特征和解释：一项匹配的病例对照研究。
Abdom Radiol (NY). 2022 Dec;47(12):4160-4172. doi: 10.1007/s00261-022-03671-6. Epub 2022 Sep 21.
6
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds.家族性胰腺癌患者的长期前瞻性随访中胰腺癌发病风险。
J Natl Cancer Inst. 2022 Dec 8;114(12):1681-1688. doi: 10.1093/jnci/djac167.
7
Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.综合家族史和基因分析对多学科胰腺肿瘤临床诊疗的影响。
Cancer Med. 2023 Feb;12(3):2345-2355. doi: 10.1002/cam4.5059. Epub 2022 Jul 30.
8
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.多中心胰腺癌筛查研究：对分期和生存的影响。
J Clin Oncol. 2022 Oct 1;40(28):3257-3266. doi: 10.1200/JCO.22.00298. Epub 2022 Jun 15.
9
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.携带种系致病变异者的胰腺癌监测：20年前瞻性随访的结果与转归
J Clin Oncol. 2022 Oct 1;40(28):3267-3277. doi: 10.1200/JCO.22.00194. Epub 2022 Jun 3.
10
Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.新发糖尿病患者胰腺的影像学表现：一项前瞻性初步研究。
Clin Transl Gastroenterol. 2022 Jun 1;13(6):e00478. doi: 10.14309/ctg.0000000000000478.
Zotero 插件